Lipoprotein particle sizes and incident type 2 diabetes: the PREVEND cohort study.

Autor: Sokooti S; Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. s.sokooti.oskooei@umcg.nl., Flores-Guerrero JL; Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Garcia E; Laboratory Corporation of America® Holdings (Labcorp), Morrisville, NC, USA., Connelly MA; Laboratory Corporation of America® Holdings (Labcorp), Morrisville, NC, USA., Bakker SJL; Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Dullaart RPF; Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Jazyk: angličtina
Zdroj: Diabetologia [Diabetologia] 2022 Feb; Vol. 65 (2), pp. 402-405. Date of Electronic Publication: 2021 Nov 20.
DOI: 10.1007/s00125-021-05603-3
Databáze: MEDLINE